You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Colorcon
Dow
McKinsey
Merck

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

CARNITOR Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Carnitor, and when can generic versions of Carnitor launch?

Carnitor is a drug marketed by Leadiant Biosci Inc and is included in three NDAs. There are three patents protecting this drug.

This drug has four patent family members in four countries.

The generic ingredient in CARNITOR is levocarnitine. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the levocarnitine profile page.

US ANDA Litigation and Generic Entry Outlook for Carnitor

A generic version of CARNITOR was approved as levocarnitine by WEST-WARD PHARMS INT on March 29th, 2001.

  Start Trial

Drug patent expirations by year for CARNITOR
Drug Prices for CARNITOR

See drug prices for CARNITOR

Recent Clinical Trials for CARNITOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Physicians' Services Incorporated FoundationPhase 4
University Health Network, TorontoPhase 4
The Gerber FoundationPhase 2/Phase 3

See all CARNITOR clinical trials

Pharmacology for CARNITOR

US Patents and Regulatory Information for CARNITOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Leadiant Biosci Inc CARNITOR SF levocarnitine SOLUTION;ORAL 019257-002 Mar 28, 2007 AA RX Yes No   Start Trial   Start Trial   Start Trial
Leadiant Biosci Inc CARNITOR levocarnitine SOLUTION;ORAL 018948-002 Apr 27, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Colorcon
Dow
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.